These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18328902)

  • 1. Delayed allergic reactions to omalizumab: are patients reporting all cases?
    Barry PJ; O'Mahony A; Finnegan C; O'Connor TM
    J Allergy Clin Immunol; 2008 Mar; 121(3):785-6; author reply 786. PubMed ID: 18328902
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma.
    Limb SL; Starke PR; Lee CE; Chowdhury BA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1378-81. PubMed ID: 17936893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
    Lin RY; Rodriguez-Baez G; Bhargave GA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):442-5. PubMed ID: 19927545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an anaphylactoid reaction to omalizumab.
    Dreyfus DH; Randolph CC
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):624-7. PubMed ID: 16680936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis.
    Cox L; Platts-Mills TA; Finegold I; Schwartz LB; Simons FE; Wallace DV; ;
    J Allergy Clin Immunol; 2007 Dec; 120(6):1373-7. PubMed ID: 17996286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lichen planus associated with omalizumab administration in an adult with allergic asthma.
    Seeborg FO; Rihal PS; Czelusta A; Sanchez R; Hanson IC
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):349-51. PubMed ID: 19445051
    [No Abstract]   [Full Text] [Related]  

  • 8. [New drugs; omalizumab].
    Cohen AF; Dubois EA; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2871-2. PubMed ID: 17319219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab for asthma.
    Tonnel AB; Tillie-Leblond I
    N Engl J Med; 2006 Sep; 355(12):1282. PubMed ID: 16998966
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaphylactoid reactions in two patients after omalizumab administration after successful long-term therapy.
    Price KS; Hamilton RG
    Allergy Asthma Proc; 2007; 28(3):313-9. PubMed ID: 17619560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab in children: a negative risk-benefit balance in severe persistent asthma.
    Prescrire Int; 2011 Apr; 20(115):92. PubMed ID: 21648208
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe serum sickness-like syndrome after omalizumab therapy for asthma.
    Pilette C; Coppens N; Houssiau FA; Rodenstein DO
    J Allergy Clin Immunol; 2007 Oct; 120(4):972-3. PubMed ID: 17716723
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of omalizumab and steroids in Churg-Strauss syndrome.
    Spina MF; Miadonna A
    J Allergy Clin Immunol; 2009 Sep; 124(3):600-1. PubMed ID: 19631973
    [No Abstract]   [Full Text] [Related]  

  • 15. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
    Liebhaber M; Dyer Z
    J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
    Ruppert AM; Averous G; Stanciu D; Deroide N; Riehm S; Poindron V; Pauli G; Debry C; de Blay F
    J Allergy Clin Immunol; 2008 Jan; 121(1):253-4. PubMed ID: 18206510
    [No Abstract]   [Full Text] [Related]  

  • 17. Omalizumab for asthma.
    Winchester DE; Jacob A; Murphy T
    N Engl J Med; 2006 Sep; 355(12):1281-2. PubMed ID: 16990394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Omalizumab. A monoclonal antibody against IgE].
    Hennemann A
    Med Monatsschr Pharm; 2004 Dec; 27(12):404-7. PubMed ID: 15646688
    [No Abstract]   [Full Text] [Related]  

  • 19. Omalizumab: overview of pharmacology and efficacy in asthma.
    Ledford DK
    Expert Opin Biol Ther; 2009 Jul; 9(7):933-43. PubMed ID: 19527111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab (Xolair) in patients with steroid-resistant asthma: lessons to be learnt.
    Thompson PJ; Misso NL; Woods J
    Respirology; 2007 Nov; 12 Suppl 3():S29-34; discussion S45-7. PubMed ID: 17956517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.